Skip to main content
Premium Trial:

Request an Annual Quote

The Money of Sequencing

There has been an increasing number of cases in which people have been helped medically by knowing their genome, and Forbes' Matthew Herper adds that "these pioneers have followed a path we're all likely to trod down — and one that the business world has not even begun to figure out how to monetize." Herper goes on to say that while the price of DNA sequencing is falling quickly — he mentions the price war between Illumina and Life Tech as well as the influx of new approaches from PacBio, Complete Genomics, and others as driving that decline — it's uncertain if sequencing will be the commodity or the interpretation of those sequences. "Researchers are building a road we'll all walk on. At some point, somebody has to figure out where to put the tolls," he says.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.